DIRAS1 and cancer: However, western blot results showed that DIRAS1 protein levels were not significantly altered after inhibitor treatment, suggesting the existence of a more critical post-transcriptional regulatory mechanism for DIRAS1 that further controls the low-level expression of DIRAS1 protein in cancer cells.